3.36
price up icon0.30%   0.010
after-market Dopo l'orario di chiusura: 3.40 0.04 +1.19%
loading

Pyxis Oncology Inc Borsa (PYXS) Ultime notizie

pulisher
09:09 AM

Millennium Management LLC Reduces Stake in Pyxis Oncology Inc - GuruFocus

09:09 AM
pulisher
02:17 AM

Is Pyxis Oncology Inc. stock a top pick in earnings seasonBear Alert & Verified Momentum Stock Alerts - Trung tâm Dự báo KTTV quốc gia

02:17 AM
pulisher
12:01 PM

Smart tools for monitoring Pyxis Oncology Inc.’s price action2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com

12:01 PM
pulisher
09:59 AM

Developing predictive dashboards with Pyxis Oncology Inc. dataDay Trade & Low Risk Investment Opportunities - newser.com

09:59 AM
pulisher
02:55 AM

Live market analysis of Pyxis Oncology Inc.2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com

02:55 AM
pulisher
02:29 AM

Full technical analysis of Pyxis Oncology Inc. stock2025 Trade Ideas & Reliable Intraday Trade Alerts - newser.com

02:29 AM
pulisher
Oct 16, 2025

Will Pyxis Oncology Inc. stock deliver better than expected guidance2025 Technical Overview & Smart Investment Allocation Tips - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Pyxis Oncology (NASDAQ:PYXS) Upgraded at Zacks Research - Defense World

Oct 16, 2025
pulisher
Oct 15, 2025

Will Pyxis Oncology Inc. stock continue upward momentumEarnings Overview Summary & Weekly Breakout Stock Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How risky is Pyxis Oncology Inc. stock nowJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Why Pyxis Oncology Inc. stock is a value investor pickIPO Watch & Weekly High Return Opportunities - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance

Oct 15, 2025
pulisher
Oct 15, 2025

Strategies to average down on Pyxis Oncology Inc.Chart Signals & Reliable Price Action Trade Plans - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

What makes Pyxis Oncology Inc. stock attractive to growth fundsQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com

Oct 14, 2025
pulisher
Oct 14, 2025

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance

Oct 14, 2025
pulisher
Oct 13, 2025

Pyxis Oncology to Present Translational Data and Key - GlobeNewswire

Oct 13, 2025
pulisher
Oct 13, 2025

ctDNA reduction in 37 clinical samples: Pyxis Oncology presents MICVO translational findings at ESMO & AACR 2025 - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

Can Pyxis Oncology Inc. stock beat analyst upgradesTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Pyxis Oncology Gains 70%, Insider Trades Reap Benefit - 富途牛牛

Oct 10, 2025
pulisher
Oct 10, 2025

Pyxis Oncology (NASDAQ:PYXS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Will Pyxis Oncology Inc. see short term momentumVolume Spike & Pattern Based Trade Signal System - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Pyxis Oncology Inc. stock undervalued vs historical averages2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time pattern detection on Pyxis Oncology Inc. stockMarket Growth Report & Community Consensus Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Pyxis Oncology, Inc. Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets, Effective October 9, 2025 - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Pyxis Oncology appoints Alex Kane as SVP of investor relations By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - Quiver Quantitative

Oct 09, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):